Log in to save to my catalogue

What Is New in Morphea—Narrative Review on Molecular Aspects and New Targeted Therapies

What Is New in Morphea—Narrative Review on Molecular Aspects and New Targeted Therapies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11642389

What Is New in Morphea—Narrative Review on Molecular Aspects and New Targeted Therapies

About this item

Full title

What Is New in Morphea—Narrative Review on Molecular Aspects and New Targeted Therapies

Publisher

Switzerland: MDPI AG

Journal title

Journal of clinical medicine, 2024-12, Vol.13 (23), p.7134

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Morphea, also known as localized scleroderma, is an autoimmune chronic connective tissue disease. It is characterized by excessive collagen deposition in the dermis and/or subcutaneous tissue. The etiopathogenesis of this disease is not fully understood, with endothelial cell damage, immunological disorders, extracellular matrix disorders and facto...

Alternative Titles

Full title

What Is New in Morphea—Narrative Review on Molecular Aspects and New Targeted Therapies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11642389

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11642389

Other Identifiers

ISSN

2077-0383

E-ISSN

2077-0383

DOI

10.3390/jcm13237134

How to access this item